A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
Xiaobo Shi,Xiaoxiao Liu,Shupei Pan,Yue Ke,Yuxing Li,Wei Guo,Yuchen Wang,Qinli Ruan,Xiaozhi Zhang,Hongbing Ma
DOI: https://doi.org/10.2147/IJGM.S333697
IF: 2.145
2021-11-17
International Journal of General Medicine
Abstract:Xiaobo Shi, 1 Xiaoxiao Liu, 1 Shupei Pan, 1 Yue Ke, 1 Yuxing Li, 1 Wei Guo, 1 Yuchen Wang, 1 Qinli Ruan, 1 Xiaozhi Zhang, 2 Hongbing Ma 1 1 Department of Radiation Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China; 2 Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China Correspondence: Hongbing Ma Department of Radiation Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157, Xi Wu Road, Xi'an, 710004, Shaanxi, People's Republic of China Tel +86 13991845066 Email Background: Considering the significance of autophagy and long non-coding RNAs (lncRNAs) in the biology of esophageal squamous cell carcinoma (ESCC), the present study aimed to identify a new autophagy-related lncRNA signature to forecast the clinical outcomes of ESCC patients and to guide individualized treatment. Methods: The expression profiles were obtained from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) database. We extracted autophagy-related genes from the Human Autophagy Database and identified autophagy-related lncRNAs through Spearman correlation analysis. Univariate, least absolute shrinkage and selection operator and multivariate Cox regression analyses were performed on GSE53625 to construct an autophagy-related lncRNAs prognostic signature. The model was subjected to bootstrap internal validation, and the expression levels of lncRNAs were verified by TCGA database. The potential molecular mechanism of the model was explored by gene set enrichment analysis (GSEA). Spearman correlation coefficient examined the correlation between risk score and ferroptosis-associated genes as well as the response to immunotherapy and chemotherapy. Results: We identified and validated an autophagy-related lncRNAs prognostic signature in 179 patients with ESCC. The prognosis of patients in the low-risk group was significantly better than that in the high-risk group ( p -value < 0.001). The reliability of the model was verified by Brier score and ROC. GSEA results showed significant enrichment of cancer- and autophagy-related signaling pathways in the high-risk group and metabolism-related pathways in the low-risk group. Correlation analysis indicated that the model can effectively forecast the effect of immunotherapy and chemotherapy. About 35.41% (74/209) ferroptosis-related genes were significantly correlated with risk scores. Conclusion: In brief, we constructed a novel autophagy-related lncRNAs signature (LINC02024, LINC01711, LINC01419, LCAL1, FENDRR, ADAMTS9-AS1, AC025244.1, AC015908.6 and AC011997.1), which could improve the prediction of clinical outcomes and guide individualized treatment of ESCC patients. Keywords: autophagy, esophageal squamous cell carcinoma, lncRNA, prognosis, therapeutic response Esophageal carcinoma is the most common malignant tumor of the digestive system, which includes two principal pathological subtypes: squamous cell carcinoma and adenocarcinoma. 1 In China, the main pathological type of esophageal cancer is esophageal squamous cell carcinoma (ESCC), accounting for more than 90% of the total cases. 2 In the past few decades, although the diagnosis and treatment strategies of ESCC have made great progress, the overall survival rate is still poor, with a 5-year survival rate of only about 15–25%. 3–5 Hence, the development of new effective prognostic biomarkers to guide ESCC treatment is imperative. Autophagy is a physiological process during which cells use lysosomes to degrade damaged organelles and macromolecular substances. 6 Currently, autophagy appears to play dual roles in tumorigenesis, maintenance, and tumor progression. In the process of tumor initiation and malignant transformation, autophagy exerted a tumor-suppressive role. However, in the process of tumor progression, autophagy can act as an oncogenic mechanism by promoting tumor cell metastasis and inhibiting tumor cell apoptosis. 7 Current literature shows that autophagy is associated with the diagnosis, treatment and prognosis of ESCC patients. 8 Long non-coding RNAs (lncRNAs) generally refer to the non-coding RNAs, which are at least 200 nucleotides in length. 9 With the continuous deepening of research in recent years, lncRNAs have engaged much attention. There is a growing literature that lncRNAs play a key role in gene regulation, thus affecting a variety of biological processes, including tumor cell proliferation, differentiation, metastasis and apoptosis. 10,11 Recent stu -Abstract Truncated-
medicine, general & internal